<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04909411</url>
  </required_header>
  <id_info>
    <org_study_id>2018/CHU/07</org_study_id>
    <nct_id>NCT04909411</nct_id>
  </id_info>
  <brief_title>Consequences of a Maternal-fetal Chikungunya Virus Infection</brief_title>
  <acronym>CHIK13+</acronym>
  <official_title>Consequences of a Maternal-fetal Chikungunya Virus Infection. Neurocognitive and Sensory Assessment Around the Age of 13.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de la Réunion</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de la Réunion</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chikungunya is an infectious disease caused by an alphavirus transmitted by the Aedes&#xD;
      mosquitoes which has known a worldwide expansion since its re-emergence in 2004. Regarding to&#xD;
      an unprecedented epidemic, Reunionese pediatricians described in 2005-2006 a vertical&#xD;
      maternal-fetal transmission of this virus, at the time of childbirth. Since then, this mode&#xD;
      of transmission has been widely confirmed, with an absolute risk estimated between 15.5% and&#xD;
      48.3%. The main consequences for the child are neuromotor, neurosensory or neurocognitive.&#xD;
      They were studied around the age of 2 in 33 children in the CHIMERE cohort, as well as at the&#xD;
      age of 5 in a small fraction of these children followed at the C.A.M.S.P (Center for Early&#xD;
      Medico-Social Action). The results suggested an overall delay in psychomotor acquisitions&#xD;
      secondary to neonatal infection, affecting the functions of the prefrontal region (in&#xD;
      particular coordination and language). Performance was correlated with the severity of the&#xD;
      clinical presentation (more severe in case of encephalitis or encephalopathy) while remaining&#xD;
      suboptimal in children with uncomplicated infection. During neurodevelopmental monitoring,&#xD;
      other disturbing traits complemented the spectrum of problems presented by these children,&#xD;
      such as microcephaly, cerebral palsy, epilepsy, interaction disorder or attention deficit&#xD;
      disorder. At around age 10, the investigators reassessed 21 of these children using the&#xD;
      Childhood Cognitive Function and Learning (EDA) screening test. The investigators would now&#xD;
      like to confirm and characterize their impairments using a battery of confirmatory tests&#xD;
      around the age of 13.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 13, 2020</start_date>
  <completion_date type="Anticipated">January 12, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 12, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total intelligence quotient</measure>
    <time_frame>Month 3 (+/- 1 month)</time_frame>
    <description>Evaluation of total intelligence quotient with Wechsler Intelligence Scale for Children-5</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Chikungunya Virus Infection</condition>
  <arm_group>
    <arm_group_label>Exposed arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>child infected with chikungunya virus during childbirth</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-exposed arm</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>child not infected with the chikungunya virus at the time of childbirth, verifying the matching criteria specified</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>OPHTHALMOLOGICAL ASSESSMENT</intervention_name>
    <description>assessment of eye mobility (search for heterophoria or strabismus), visual acuity, visual fields, external structures and funduscopic examination</description>
    <arm_group_label>Exposed arm</arm_group_label>
    <arm_group_label>Non-exposed arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NEUROPSYCHOLOGICAL ASSESSMENT</intervention_name>
    <description>completion of WISC-5, Vineland Adaptive Behavior Scale II and Strengths and Difficulties Questionnaire</description>
    <arm_group_label>Exposed arm</arm_group_label>
    <arm_group_label>Non-exposed arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Child born between March 2005 and July 2006&#xD;
&#xD;
          -  Of which the mother identified in the CHIMERE cohort or the perinatal register of&#xD;
             maternities&#xD;
&#xD;
          -  Exposed: child infected with the chikungunya virus at the time of childbirth&#xD;
&#xD;
          -  Not exposed: child not infected with the chikungunya virus at the time of childbirth,&#xD;
             verifying the matching criteria specified in chapter 5.2&#xD;
&#xD;
          -  Affiliated to a social insurance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Prematurity &lt;33 weeks&#xD;
&#xD;
          -  Prenatal alcoholization authenticated by fetal alcohol syndrome&#xD;
&#xD;
          -  Intellectual disability or secondary epilepsy of origin other than CHIKV infection&#xD;
             (caused by ACSOS or any other cause of brain damage of inflammatory, metabolic or&#xD;
             infectious origin)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raphaelle SARTON, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de La Réunion</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Samir MEDJANE, PhD</last_name>
    <phone>+262(0)267359750</phone>
    <email>samir.medjane@chu-reunion.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de La Réunion</name>
      <address>
        <city>Saint-Pierre</city>
        <zip>97410</zip>
        <country>Réunion</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raphaelle SARTON, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Réunion</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 28, 2021</study_first_submitted>
  <study_first_submitted_qc>May 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2021</study_first_posted>
  <last_update_submitted>June 2, 2021</last_update_submitted>
  <last_update_submitted_qc>June 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Virus Diseases</mesh_term>
    <mesh_term>Chikungunya Fever</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

